COMP <GO>
AMN vs TSLA // 10Y YIELD & FRED MACRO BETA
AMN Healthcare Services Inc (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: AMN 3
— TSLA 6
■ METRIC PARITY
LAST: $46.94 (+0.47%) • MKT CAP: $1.82B
macro-sensitivity
—
LAST: $403.30 (-0.23%) • MKT CAP: $1.59T
macro-sensitivity
1.89
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMN VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMN | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.30% | 19.29% | +9.01 | AMN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.20% | 3.39% | -10.59 | TSLA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 199.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.86% | 0.21% | +12.65 | AMN | /fcf-yield <GO> |
| Operating Margin | -2.00% | 3.35% | -5.35 | TSLA | /operating-margins <GO> |
| Net Profit Margin | -3.50% | 3.11% | -6.61 | TSLA | /net-margins <GO> |
| Revenue Growth (YoY) | -8.50% | 8.30% | -16.80 | TSLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.76 | 15.35 | -12.59 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 8.72% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.9 | 56.6 | +19.31 | AMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.89 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.82B | $1.59T | -$1.59T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMN REV | TSLA REV | AMN GROSS % | TSLA GROSS % | AMN FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.73B | $94.83B | 28.3% | 18.0% | $233.8M | $6.22B |
| FY 2024 | $2.98B | $97.69B | 30.8% | 17.9% | $239.5M | $3.58B |
| FY 2023 | $3.79B | $96.77B | — | 18.3% | $372.2M | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMN // BETA —
TSLA // BETA 1.89